Professor Wei Wenbin: Complex Retina and Eye Tumor Specialist
Professor Wei Wenbin is a senior ophthalmologist, professor, doctoral supervisor, vice president of Beijing Tongren Hospital, and chief expert in ophthalmology. His clinical and academic work focuses on complex retinal and vitreous disease, retinal detachment surgery, intraocular tumors, eye-preserving treatment for retinoblastoma, retinal imaging, and artificial-intelligence-assisted diagnosis.
Clinical and Academic Focus
- complex retinal detachment;
- vitreoretinal microsurgery;
- proliferative diabetic retinopathy;
- macular and posterior-segment disease;
- retinoblastoma and eye-preserving treatment;
- adult intraocular tumors;
- ocular imaging and multimodal diagnosis;
- recurrent disease after previous eye surgery; and
- second opinions before removal of an eye or high-risk retinal surgery.
Retinal Detachment
Retinal detachment occurs when the light-sensitive retina separates from the tissue beneath it. New flashes, a sudden increase in floaters, a curtain-like shadow, or rapid vision loss requires urgent local ophthalmic assessment.
Treatment may involve laser, gas injection, scleral buckle, vitrectomy, silicone oil, or a combined operation. The choice depends on the tear, detachment extent, lens status, scar tissue, previous surgery, and involvement of the macula.
Complex Vitreoretinal Surgery
Vitrectomy removes the vitreous gel and allows treatment of retinal tears, bleeding, membranes, scar tissue, foreign bodies, infection, or traction. Complex cases can require membrane peeling, retinectomy, endolaser, heavy liquids, gas, or silicone oil.
Visual recovery depends on the underlying disease, duration, macular and optic-nerve damage, infection, and previous procedures. Anatomical reattachment does not guarantee normal vision.
Diabetic Retinopathy
Advanced diabetic retinopathy can cause bleeding, tractional retinal detachment, macular swelling, and severe vision loss. Management may include glucose and blood-pressure control, anti-VEGF injections, laser, and surgery.
Traction near the macula or combined tractional and rhegmatogenous detachment may require complex vitreoretinal repair.
Retinoblastoma
Retinoblastoma is a childhood retinal cancer that can threaten life and vision. Treatment priorities are survival first, then preservation of the eye and useful vision when medically safe.
Options can include systemic, intra-arterial, or intravitreal chemotherapy, laser, cryotherapy, plaque radiotherapy in selected settings, or removal of the eye. Management requires an experienced pediatric ocular-oncology team.
Professor Wei pioneered eye-preserving approaches for selected intraocular tumors in China. Eligibility depends on tumor extent, seeding, optic-nerve involvement, spread outside the eye, prior treatment, and current hospital protocols.
Adult Intraocular Tumors
Adult eye tumors include uveal melanoma, metastasis, lymphoma, vascular tumors, and benign lesions that can mimic cancer. Evaluation may use fundus photography, ultrasound, OCT, angiography, MRI, systemic imaging, and sometimes biopsy.
Treatment can include observation, local resection, laser, radiotherapy, systemic therapy, or enucleation depending on diagnosis and risk.
Eye-Preserving Treatment
Preserving the eye is not appropriate when it compromises cancer control or patient safety. A second opinion should review original imaging, pathology, treatment history, and the risk of spread.
Families should be cautious about any promise of guaranteed eye or vision preservation.
Retinal Imaging and Artificial Intelligence
Wide-field photography, OCT, angiography, autofluorescence, and ocular ultrasound help document disease and treatment response. Professor Wei’s team has also developed artificial-intelligence research for retinoblastoma screening and classification.
AI can support detection and triage but does not replace examination by an ocular-oncology specialist.
Who May Consider a Consultation?
- patients with complex or recurrent retinal detachment;
- patients needing vitreoretinal surgery after previous failed repair;
- patients with advanced diabetic eye disease;
- children with suspected or confirmed retinoblastoma;
- families seeking review before enucleation;
- adults with an intraocular mass or uncertain diagnosis;
- patients needing multimodal retinal-imaging review; or
- patients seeking a second opinion on eye- and vision-preserving options.
Medical Records to Prepare
- a concise eye symptom and treatment timeline;
- visual-acuity and eye-pressure records;
- fundus photographs, wide-field imaging, OCT, angiography, and autofluorescence;
- ocular ultrasound and MRI or CT in original format;
- all retinal, tumor, injection, laser, and operative reports;
- pathology slides, paraffin blocks, and molecular reports when available;
- systemic cancer staging and pediatric oncology records;
- genetic testing and family history for retinoblastoma;
- a complete medication history; and
- a clear list of life-, eye-, and vision-preservation goals.
Planning an International Consultation
Sudden vision loss, flashes with a curtain-like shadow, severe eye pain, suspected infection, or a rapidly changing eye tumor requires urgent local ophthalmic care.
Stable patients should confirm whether original images, videos, pathology, and oncology records can be reviewed. Remote medical-record review requires physician authorization. Final diagnosis and treatment eligibility usually require in-person examination under appropriate ophthalmic conditions.
How CMCS Can Assist
CMCS – China Medical Concierge Shanghai is an independent medical concierge and health management company, not a hospital. We assist international patients with organizing and translating ophthalmology and oncology records, identifying an appropriate specialist, requesting appointment availability, arranging interpretation, and planning medical travel in China.
Access to Professor Wei, remote review, surgery, chemotherapy, eye-preserving treatment, or a particular technology is subject to doctor and hospital approval. CMCS does not guarantee appointments, eye preservation, vision recovery, treatment eligibility, or clinical outcomes.
- Email: contract@medicalsh.com
- WhatsApp: Contact us on WhatsApp
- Website: www.medicalsh.com
Important Note
Doctor titles, clinical roles, medicines, procedures, devices, and appointment arrangements may change. This profile is based on the supplied verified research document and is for general information only. It does not replace assessment by a qualified ophthalmology and ocular-oncology team.
0 comments